«INFLAMMATORY PROTEINS, GENETIC VARIATION, AND ENVIRONMENTAL INFLUENCES ON HEALTH CARE ASSOCIATED INFECTION DEVELOPMENT IN SEPSIS A Dissertation ...»
109. Barnes MR. Navigating the HapMap. Briefings in Bioinformatics 2006;7:211-24.
110. Tramont E. Host defense mechanisms: general or nonspecific host defense mechanisms. In: Mandell GL, Douglas RG, Jr., Bennett JE, eds. Principles and Practices of Infectious Diseases. New York, NY: Churchill Livingston Inc.;
111. Horan TC, Gaynes R. Surveillence of nosocomial infections. In: Mayhall CG, ed.
Hospital epidemiology and infection control. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:1659-702.
112. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control 2008;36:309-32.
113. Cannon JG, Nerad JL, Poutsiaka DD, Dinarello CA. Measuring circulating cytokines. Journal of Applied Physiology 1993;75:1897-902.
114. Fahey JL, Aziz N, Spritzler J, et al. Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation.
Clinical and Diagnostic Laboratory Immunology 2000;7:540-8.
115. Mire-Sluis AR, Das RG, Padilla A. WHO cytokine standardization: facilitating the development of cytokines in research, diagnosis and as therapeutic agents.
Journal of Immunological Methods 1998;216:103-16.
116. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
Journal of Chronic Diseases 1987;40:373-83.
117. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation 2003;108:3006-10.
118. Boos CJ, Anderson RA, Lip GY. Is atrial fibrillation an inflammatory disorder?
European Heart Journal 2006;27:136-49.
119. Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F. Gender differences in human sepsis. Archives of Surgery 1998;133:1200-5.
120. Mayr FB, Yende S, Linde-Zwirble WT, et al. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. Journal of the American Medical Association 2010;303:2495-503.
121. Klevay MJ, Ernst EJ, Hollanbaugh JL, Miller JG, Pfaller MA, Diekema DJ.
Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection. Diagnostic Microbiology and Infectious Diseases 2008;60:273-7.
122. Mean M, Marchetti O, Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Critical Care (London, England) 2008;12:204.
123. Lundstrom T, Sobel J. Nosocomial candiduria: a review. Clinical Infectious Diseases 2001;32:1602-7.
124. Cohen Y, Karoubi P, Adrie C, et al. Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients. Critical Care Medicine 2010;38:826-30.
125. Marik PE. Critical illness-related corticosteroid insufficiency. Chest 2009;135:181-93.
126. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007;131:954-63.
127. Ramirez P, Ferrer M, Gimeno R, et al. Systemic inflammatory response and increased risk for ventilator-associated pneumonia: a preliminary study. Critical Care Medicine 2009;37:1691-5.
128. Baier RJ, Loggins J, Yanamandra K. IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants. BMC Medicine 2006;4:10.
129. Zubert S, Funk DJ, Kumar A. Antibiotics in sepsis and septic shock: like everything else in life, timing is everything. Critical Care Medicine 2010;38:1211-2.
130. Kumar A. Optimizing antimicrobial therapy in sepsis and septic shock. Critical Care Nursing Clinics of North America 2011;23:79-97.
131. Manginas A, Tsiavou A, Chaidaroglou A, et al. Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coronary Artery Disisease 2008;19:575-82.
APPENDIX A. VETERAN’S ADMINISTRATION MEDICAL CENTER
INSTITUTIONAL REVIEW BOARD INITIAL APPROVAL
APPENDIX B. VETERAN’S ADMINISTRATION RESEARCH AND
DEVELOPMENT COMMITTEE ANNUAL REVIEW
APPENDIX C. THE UNIVERSITY OF TENNESSEE HEALTH SCIENCE
CENTER INSTITUTIONAL REVIEW BOARD INITIAL APPROVAL
APPENDIX D. VETERAN’S ADMINISTRATION RESEARCH CONSENT FORM
APPENDIX E. DATA COLLECTION FORMS
Reba Antionette Umberger was born in Memphis, TN in 1966. After graduating from Olive Branch High School, she attended Northwest Mississippi Junior College and received the degree of Associate of Science in Nursing in 1987. Subsequently she entered the University of Memphis and earned a Bachelor of Science degree in biology (microbiology) in
1994. She later pursued graduate education at the University of Tennessee Health Science in 2001 and enrolled in the Master of Science program in epidemiology, earning the M.S.
degree in 2004. Reba began doctoral studies in 2006 and will graduate with a Doctor of Philosophy in Nursing from The University of Tennessee Health Science Center in May
2011. She completed a fellowship in genetics at the National Institutes of Health (2008).
She has worked in critical care for more than 20 years, at the bedside and in research, and